Synphne

SynPhNe™ is revolutionizing stroke and TBI rehabilitation with the first wearable solution to synchronize cognition and motor function training. Using real-time EEG and EMG data, our technology forms a self-correcting learning loop, providing deficit insights that allow for patient-specific rehabilitation. We are currently partnered with renowned US hospitals and our platform is available for commercial use underpinned by our FDA Class II 510(k) exempt status. Additional operations, including our global headquarters, are located in Asia. While our core expertise lies in neurorehabilitation, Synphne has also launched initial commercial operations in Sports Peak Performance in Asia and successfully completed preliminary studies in the Learning Disability domain.